EVO

1.3208.97%
IM

Ingrid Mller

COO & Member of Management Board

Dr. Ingrid Mller has been the Chief Operating Officer and Member of Management Board of Evotec SE from May 1, 2026. She has to Evotec many years of international leadership experience in the life sciences industry across operations, strategy, supply, procurement and R&D integration. Most recently, Dr. Mller served as Vice President Portfolio Strategy & Execution at CureVac. Prior to that, she held senior international leadership roles at Sanofi and Fresenius Kabi, where she was instrumental in strengthening supply resilience, implementing make-or-buy strategies, supporting growth and margin expansion and delivering annual savings and cash-flow improvements. Dr. Müller began her professional career at Fresenius Kabi, where she worked as Director Innovation & Project Portfolio Management Pharmaceuticals and as Clinical Project Manager in innovation and global portfolio roles, contributing to international product launches, life-cycle management and geographic expansion initiatives. Dr. Müller holds a doctorate in natural sciences and a diploma in Biochemistry from Johann Wolfgang Goethe University in Frankfurt am Main. She has completed executive education at INSEAD and other leading business schools.

Positions